Concept

Pediatric Cancers

Cancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute / What the Report Means for Immunotherapy

"Accelerate research for pediatric cancers: While five-year survival rates for some childhood cancers have improved dramatically (for example, leukemia has improved from 50% in the mid 1970s to 89% in 2015–2021), one in six survivors faces major cardiovascular events by age 50, highlighting the need for gentler, more effective treatments."

Related Ideas

  • Drug DiscoveryFuture of Cancer Science | AACR Cancer Progress Report 2025 · Advancing New Treatments
  • Early DiagnosisFuture of Cancer Science | AACR Cancer Progress Report 2025 · Diagnosing Cancer and Predicting Metastases
  • Immunotherapy ReachCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · What the Report Means for Immunotherapy
  • Survival GainsCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Immunotherapy Is Helping Rewrite Survival Curves
  • Cancer ProgressCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
  • Research ProgressCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · The Road Ahead
  • Equal AccessCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · The Road Ahead
  • Immune ResponseFuture of Cancer Science | AACR Cancer Progress Report 2025 · Monitoring Treatment Response and Predicting Resistance
Pediatric Cancers | Cancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute | Bifalgorithm | Bifalgorithm